Literature DB >> 28698189

A comprehensive review on MEN2B.

Frederic Castinetti1, Jeffrey Moley2, Lois Mulligan3, Steven G Waguespack4.   

Abstract

MEN2B is a very rare autosomal dominant hereditary tumor syndrome associated with medullary thyroid carcinoma (MTC) in 100% cases, pheochromocytoma in 50% cases and multiple extra-endocrine features, many of which can be quite disabling. Only few data are available in the literature. The aim of this review is to try to give further insights into the natural history of the disease and to point out the missing evidence that would help clinicians optimize the management of such patients. MEN2B is mainly characterized by the early occurrence of MTC, which led the American Thyroid Association to recommend preventive thyroidectomy before the age of 1 year. However, as the majority of mutations are de novo, improved knowledge of the nonendocrine signs would help to lower the age of diagnosis and improve long-term outcomes. Future large-scale studies will be aimed at characterizing more in detail the main characteristics and outcomes of MEN2B.
© 2018 Society for Endocrinology.

Entities:  

Keywords:  RET; ganglioneuromas; marfanoid; medullary thyroid cancer; pheochromocytoma

Mesh:

Substances:

Year:  2017        PMID: 28698189     DOI: 10.1530/ERC-17-0209

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  15 in total

1.  Pheochromocytoma in Children and Adolescents With Multiple Endocrine Neoplasia Type 2B.

Authors:  Angeliki Makri; Srivandana Akshintala; Claudia Derse-Anthony; Jaydira Del Rivero; Brigitte Widemann; Constantine A Stratakis; John Glod; Maya Lodish
Journal:  J Clin Endocrinol Metab       Date:  2019-01-01       Impact factor: 5.958

2.  Pulmonary Function in Patients With Multiple Endocrine Neoplasia 2B.

Authors:  Sarah Fuller; Jaydira Del Rivero; David Venzon; Maran Ilanchezhian; Deborah Allen; Les Folio; Alexander Ling; Brigitte Widemann; Joseph R Fontana; John Glod
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

3.  New Concepts About Familial Isolated Hyperparathyroidism.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2019-03-08       Impact factor: 5.958

4.  Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for Years.

Authors:  Angeliki Makri; Srivandana Akshintala; Claudia Derse-Anthony; Brigitte Widemann; Constantine A Stratakis; John Glod; Maya Lodish
Journal:  J Pediatr       Date:  2018-10-09       Impact factor: 4.406

Review 5.  MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives.

Authors:  Vincent Amodru; David Taieb; Carole Guerin; Pauline Romanet; Nunzia Paladino; Thierry Brue; Thomas Cuny; Anne Barlier; Frederic Sebag; Frederic Castinetti
Journal:  Endocrine       Date:  2020-05-10       Impact factor: 3.633

Review 6.  Cystic ovarian teratoma as a novel tumor and growth hormone deficiency as a new condition presenting in Multiple Endocrine Neoplasia type 2B: Case reports and review of the literature.

Authors:  Renata Pomahacova; Petra Paterova; Eva Nykodymova; Eliska Vaclavikova; Pavla Sykorova; Katerina Personova; Ramir Katra; Ivan Subrt; Josef Sykora
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-08-24       Impact factor: 1.245

7.  Psychosocial Characteristics and Experiences in Patients with Multiple Endocrine Neoplasia Type 2 (MEN2) and Medullary Thyroid Carcinoma (MTC).

Authors:  Robin Lockridge; Sima Bedoya; Taryn Allen; Brigitte C Widemann; Srivandana Akshintala; John Glod; Lori Wiener
Journal:  Children (Basel)       Date:  2022-05-25

8.  Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.

Authors:  Frederic Castinetti; Steven G Waguespack; Andreas Machens; Shinya Uchino; Kornelia Hasse-Lazar; Gabriella Sanso; Tobias Else; Sarka Dvorakova; Xiao Ping Qi; Rossella Elisei; Ana Luisa Maia; John Glod; Delmar Muniz Lourenço; Nuria Valdes; Jes Mathiesen; Nelson Wohllk; Tushar R Bandgar; Delphine Drui; Marta Korbonits; Maralyn R Druce; Caroline Brain; Tom Kurzawinski; Atila Patocs; Maria Joao Bugalho; Andre Lacroix; Philippe Caron; Patricia Fainstein-Day; Francoise Borson Chazot; Marc Klein; Thera P Links; Claudio Letizia; Laura Fugazzola; Olivier Chabre; Letizia Canu; Regis Cohen; Antoine Tabarin; Anita Spehar Uroic; Dominique Maiter; Sandrine Laboureau; Caterina Mian; Mariola Peczkowska; Frederic Sebag; Thierry Brue; Delphine Mirebeau-Prunier; Laurence Leclerc; Birke Bausch; Amandine Berdelou; Akihiro Sukurai; Petr Vlcek; Jolanta Krajewska; Marta Barontini; Carla Vaz Ferreira Vargas; Laura Valerio; Lucieli Ceolin; Srivandana Akshintala; Ana Hoff; Christian Godballe; Barbara Jarzab; Camilo Jimenez; Charis Eng; Tsuneo Imai; Martin Schlumberger; Elizabeth Grubbs; Henning Dralle; Hartmut P Neumann; Eric Baudin
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-16       Impact factor: 32.069

Review 9.  The importance of the RET gene in thyroid cancer and therapeutic implications.

Authors:  Domenico Salvatore; Massimo Santoro; Martin Schlumberger
Journal:  Nat Rev Endocrinol       Date:  2021-02-18       Impact factor: 43.330

10.  Hereditary medullary thyroid carcinoma syndromes: experience from western India.

Authors:  Chakra Diwaker; Vijaya Sarathi; Sanjeet Kumar Jaiswal; Ravikumar Shah; Anuja Deshmukh; Anand Ebin Thomas; Gagan Prakash; Gaurav Malhotra; Virendra Patil; Anurag Lila; Nalini Shah; Tushar Bandgar
Journal:  Fam Cancer       Date:  2021-01-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.